Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Dec-25-22 | Dec-26-21 | Dec-27-20 | Dec-29-19 |
| 10-K | 10-K | 10-K | 10-K |
Revenues | 470.1 | 339.9 | 220.6 | 274.2 |
Revenue growth | 38.3% | 54.1% | -19.5% | |
Cost of goods sold | 400.8 | 299.5 | 229.3 | 249.6 |
Gross profit | 69.3 | 40.4 | -8.7 | 24.6 |
Gross margin | 14.7% | 11.9% | -3.9% | 9.0% |
Selling, general and administrative [+] | 187.4 | 125.0 | 99.1 | 88.8 |
General and administrative | 187.4 | 125.0 | 99.1 | 88.8 |
Other operating expenses | 10.7 | 9.2 | 4.6 | 5.4 |
EBITDA [+] | -128.6 | -93.8 | -112.4 | -50.2 |
EBITDA growth | 37.0% | -16.5% | 123.7% | |
EBITDA margin | -27.3% | -27.6% | -50.9% | -18.3% |
Depreciation | 46.5 | 35.5 | 26.9 | 19.4 |
EBITA | -175.0 | -129.4 | -139.2 | -69.7 |
EBITA margin | -37.2% | -38.1% | -63.1% | -25.4% |
Amortization of intangibles | 0.2 | | | |
EBIT [+] | -175.3 | -129.4 | -139.2 | -69.7 |
EBIT growth | 35.5% | -7.1% | 99.9% | |
EBIT margin | -37.3% | -38.1% | -63.1% | -25.4% |
Non-recurring items [+] | 18.1 | 5.0 | 2.3 | 0.4 |
Asset impairment | 2.5 | 4.9 | 1.5 | |
Loss (gain) on sale of assets | 0.3 | 0.1 | 0.9 | 0.4 |
Interest income, net [+] | 5.1 | 0.4 | 0.6 | 2.6 |
Interest expense | 0.1 | 0.1 | 0.4 | 0.1 |
Interest income | 5.1 | 0.5 | 1.0 | 2.7 |
Other income (expense), net | -0.8 | -19.0 | -0.2 | -0.5 |
Pre-tax income | -189.1 | -153.0 | -141.2 | -67.9 |
Income taxes | 1.3 | 0.1 | 0.0 | 0.0 |
Tax rate | | | 0.0% | 0.0% |
Net income | -190.4 | -153.2 | -141.2 | -67.9 |
Net margin | -40.5% | -45.1% | -64.0% | -24.8% |
|
Basic EPS [+] | ($1.73) | ($5.51) | ($8.80) | ($4.50) |
Growth | -68.6% | -37.3% | 95.4% | |
Diluted EPS [+] | ($1.73) | ($5.51) | ($8.80) | ($4.50) |
Growth | -68.6% | -37.3% | 95.4% | |
|
Shares outstanding (basic) [+] | 110.1 | 27.8 | 16.1 | 15.1 |
Growth | 296.4% | 73.1% | 6.4% | |
Shares outstanding (diluted) [+] | 110.1 | 27.8 | 16.1 | 15.1 |
Growth | 296.4% | 73.1% | 6.4% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|